Literature DB >> 8745008

Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection.

C Aznar1, P Lopez-Bergami, S Brandariz, C Mariette, P Liegeard, M D Alves, E L Barreiro, R Carrasco, S Lafon, D Kaplan.   

Abstract

Infection with Trypanosoma cruzi develops in three phases: acute, indeterminate or asymptomatic, and chronic phase (with cardiac or digestive manifestations). Moreover, transmission may occur from infected mothers to newborn, the so-called congenital form. In the present study, humoral responses against T. cruzi total extract and against the 13 amino acid peptide named R-13 derived from the parasite ribosomal P protein, previously described as a possible marker of chronic Chagas heart disease, were determined in chagasic patients and in blood bank donors from endemic areas. While in sera from acute phase, only IgM anti-T.cruzi response was observed, both IgM and IgG anti-T. cruzi antibodies were detected in sera from congenitally infected newborns. The percentage of positive response in sera from blood bank donors was relatively high in endemic regions. Antibodies against the R-13 peptide were present in a large proportion of cardiac chagasic patients but were totally lacking in patients with digestive form of Chagas' disease. Furthermore, anti-R-13 positive responses were detected in congenitally infected newborns.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8745008     DOI: 10.1111/j.1574-695X.1995.tb00197.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  12 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase.

Authors:  F S Buckner; A J Wilson; W C Van Voorhis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 3.  Anti-ribosomal-P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis, and Chagas' disease: promising yet limited in clinical utility.

Authors:  Mary Abraham; Chris T Derk
Journal:  Rheumatol Int       Date:  2014-06-07       Impact factor: 2.631

4.  Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus.

Authors:  D Kaplan; I Ferrari; P L Bergami; E Mahler; G Levitus; P Chiale; J Hoebeke; M H Van Regenmortel; M J Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.

Authors:  Sebastián Aguirre; Ariel M Silber; Maria Edileuza F Brito; María E Ribone; Claudia M Lagier; Iván S Marcipar
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

6.  Humoral immune response against P2β from Trypanosoma cruzi in persons with chronic Chagas disease: its relationship with treatment against parasites and myocardial damage.

Authors:  Diana L Fabbro; Verónica Olivera; Maria Laura Bizai; Susana Denner; Cristina Diez; Iván Marcipar; Iván Mancipar; Mirtha Streiger; Enrique Arias; Mónica del Barco; Diego Mendicino; Oscar Bottasso
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

7.  Modulation of cardiocyte functional activity by antibodies against trypanosoma cruzi ribosomal P2 protein C terminus.

Authors:  P Sepulveda; P Liegeard; G Wallukat; M J Levin; M Hontebeyrie
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

8.  The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites.

Authors:  K Rajeshwari; Kalpesh Patel; Savithri Nambeesan; Monika Mehta; Alfica Sehgal; Tirtha Chakraborty; Shobhona Sharma
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  IgG Autoantibodies Induced by T. cruzi During Pregnancy: Correlation with Gravidity Complications and Early Outcome Assessment of the Newborns.

Authors:  Miguel Hernán Vicco; Luz Rodeles; Gabriela Soledad Capovilla; Melina Perrig; Ana Gabriela Herrera Choque; Iván Marcipar; Oscar Bottasso; Celeste Rodriguez; Washington Cuña
Journal:  Matern Child Health J       Date:  2016-10

10.  Three-dimensional studies of pathogenic peptides from the c-terminal of Trypanosoma cruzi ribosomal P proteins and their interaction with a monoclonal antibody structural model.

Authors:  Osvaldo A Martín; Myriam E Villegas; Carlos F Aguilar
Journal:  PMC Biophys       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.